Traumatic hemoptysis treated with recombinant human factor VIIa

Ann Thorac Surg. 2006 Apr;81(4):1485-7. doi: 10.1016/j.athoracsur.2005.03.049.

Abstract

Blunt thoracic trauma resulting in massive hemoptysis is rare. Although there are several indications for the administration of recombinant factor VIIa, we are unaware of a report of its utilization in the treatment of hemoptysis following chest trauma. We report a case of the successful use of factor VIIa in the treatment of life-threatening hemoptysis secondary to blunt force thoracic injury and traumatic coagulopathy.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Factor VIIa / therapeutic use*
  • Female
  • Hemoptysis / drug therapy*
  • Hemoptysis / etiology*
  • Humans
  • Recombinant Proteins / therapeutic use
  • Thoracic Injuries / complications*
  • Wounds, Nonpenetrating / complications*

Substances

  • Recombinant Proteins
  • Factor VIIa